118 related articles for article (PubMed ID: 9649659)
1. Expression of cathepsins in dermal fibrous tumors: an immunohistochemical study.
Thewes M; Engst R; Boeck K; Ring J
Eur J Dermatol; 1998 Mar; 8(2):86-9. PubMed ID: 9649659
[TBL] [Abstract][Full Text] [Related]
2. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
Kahn HJ; Fekete E; From L
Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
[TBL] [Abstract][Full Text] [Related]
3. Age-related changes in activities and localizations of cathepsins D, E, B, and L in the rat brain tissues.
Nakanishi H; Tominaga K; Amano T; Hirotsu I; Inoue T; Yamamoto K
Exp Neurol; 1994 Mar; 126(1):119-28. PubMed ID: 8157122
[TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma of the vulva. Expression of tumor proteases cathepsin-D and pro-cathepsin-L.
Hantschmann P; Beysiegel S; Kurzl R
J Reprod Med; 1998 Nov; 43(11):933-42. PubMed ID: 9839260
[TBL] [Abstract][Full Text] [Related]
5. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
Kubo M; Ihn H; Yamane K; Tamaki K
Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
[TBL] [Abstract][Full Text] [Related]
6. Expression of nestin in dermatofibrosarcoma protuberans in comparison to dermatofibroma.
Mori T; Misago N; Yamamoto O; Toda S; Narisawa Y
J Dermatol; 2008 Jul; 35(7):419-25. PubMed ID: 18705829
[TBL] [Abstract][Full Text] [Related]
7. Processing of cathepsins L, B and D in psoriatic epidermis.
Kawada A; Hara K; Kominami E; Hiruma M; Noguchi H; Ishibashi A
Arch Dermatol Res; 1997 Jan; 289(2):87-93. PubMed ID: 9049042
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
de Feraudy S; Mar N; McCalmont TH
Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
[TBL] [Abstract][Full Text] [Related]
9. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma.
Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression in dermatofibroma and dermatofibrosarcoma protuberans.
Adler N; Tsabari C; Sulkes J; Ad-El D; Feinmesser M
J Cutan Pathol; 2008 Jun; 35(6):532-5. PubMed ID: 18201240
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors.
Kawasaki G; Kato Y; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Apr; 93(4):446-54. PubMed ID: 12029284
[TBL] [Abstract][Full Text] [Related]
12. CD117 immunoreactivity in atypical fibroxanthoma.
Mathew RA; Schlauder SM; Calder KB; Morgan MB
Am J Dermatopathol; 2008 Feb; 30(1):34-6. PubMed ID: 18212542
[TBL] [Abstract][Full Text] [Related]
13. The expression levels of thrombospondin-1 in dermatofibroma and dermatofibrosarcoma protuberans.
Maekawa T; Jinnin M; Ohtsuki M; Ihn H
Eur J Dermatol; 2011; 21(4):534-8. PubMed ID: 21697041
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
Sachdev R; Sundram U
J Cutan Pathol; 2006 May; 33(5):353-60. PubMed ID: 16640542
[TBL] [Abstract][Full Text] [Related]
15. Glucose controls cathepsin expression in Ras-transformed fibroblasts.
Tournu C; Obled A; Roux MP; Deval C; Ferrara M; Béchet DM
Arch Biochem Biophys; 1998 Dec; 360(1):15-24. PubMed ID: 9826424
[TBL] [Abstract][Full Text] [Related]
16. Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis.
Lah TT; Kalman E; Najjar D; Gorodetsky E; Brennan P; Somers R; Daskal I
Hum Pathol; 2000 Feb; 31(2):149-60. PubMed ID: 10685628
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer.
Castiglioni T; Merino MJ; Elsner B; Lah TT; Sloane BF; Emmert-Buck MR
Hum Pathol; 1994 Sep; 25(9):857-62. PubMed ID: 8088759
[TBL] [Abstract][Full Text] [Related]
18. Atypical fibroxanthoma: a histological and immunohistochemical review of 171 cases.
Beer TW; Drury P; Heenan PJ
Am J Dermatopathol; 2010 Aug; 32(6):533-40. PubMed ID: 20526171
[TBL] [Abstract][Full Text] [Related]
19. A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma.
Labonte S; Hanna W; Bandarchi-Chamkhaleh B
J Cutan Pathol; 2007 Nov; 34(11):857-60. PubMed ID: 17944726
[TBL] [Abstract][Full Text] [Related]
20. Endometrial carcinoma expresses an increased cathepsin B/D ratio.
Bradley WH; Lima PH; Rodgers L; Blomquist CH; Downs LS
Gynecol Oncol; 2008 Jan; 108(1):84-9. PubMed ID: 17980407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
